Hydroxychloroquine and Azithromycin to Treat Patients With COVID-19: Both Friends and Foes?

Authors :: Mégarbane B
Scherrmann JM
Source :: Journal of clinical pharmacology [J Clin Pharmacol] 2020 Jul; Vol. 60 (7), pp. 808-814. Date of Electronic Publication: 2020 May 20.
Publication Year :: 2020

Subjects :: Anti-Bacterial Agents administration & dosage
Anti-Bacterial Agents adverse effects
Betacoronavirus
COVID-19
Drug Therapy, Combination
Enzyme Inhibitors administration & dosage
Enzyme Inhibitors pharmacology
Humans
Hydroxychloroquine administration & dosage
Hydroxychloroquine pharmacology
Pandemics
Risk Assessment
SARS-CoV-2
Anti-Bacterial Agents therapeutic use
Azithromycin therapeutic use
Coronavirus Infections drug therapy
Enzyme Inhibitors therapeutic use
Hydroxychloroquine therapeutic use
Pneumonia, Viral drug therapy

Full Text Access

Tools